Exact Mass: 488.1823

Exact Mass Matches: 488.1823

Found 221 metabolites which its exact mass value is equals to given mass value 488.1823, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

beta-D-Glcp-(1->4)-alpha-L-Rhap-(1->3)-D-Glcp

beta-D-Glc-(1->4)-alpha-L-Rha-(1->3)-D-Glc; beta-D-Glcp-(1->4)-alpha-L-Rhap-(1->3)-D-Glcp

C18H32O15 (488.1741)

3-Fucosyllactose

(2S,3S,4R,5S,6S)-2-{[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-4-yl]oxy}-6-methyloxane-3,4,5-triol

C18H32O15 (488.1741)

3-Fucosyllactose is a milk oligosaccharide isolated in 1958 (PMID: 13546862), and that was also isolated for the first time from the urine of a blood group O, nonsecretor, woman during pregnancy and lactation in 1977 (PMID: 838696). Is resistant to enzymic hydrolysis in the gastrointestinal tract of the infant; it is postulated that they reach the large intestine where they serve as substrates for bacterial metabolism. (PMID 10837303). 3-Fucosyllactose is a milk oligosaccharide isolated in 1958 (PMID: 13546862), and that was also isolated for the first time from the urine of a blood group O, nonsecretor, woman during pregnancy and lactation in 1977 (PMID: 838696)

2-Fucosyllactose

(2R,3R,4R,5R)-4-{[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-2,3,5,6-tetrahydroxyhexanal

C18H32O15 (488.1741)

2-Fucosyllactose (Fuc-a( 1->2)Galb(1->4)Glc) is an oligosaccharide first found in milk in the 1950s, and a well established isolation technique was found in 1972 (PMID: 5012321). It has been used as an acceptor substrate in assays of the blood group A and B gene specified glycosyltransferases since. (PMID 6894927). 2'-Fucosyllactose (2'-FL) is an oligosaccharide that could be derived from human milk. 2'-Fucosyllactose regulates the expression of CD14, alleviates colitis and regulates the gut microbiome. 2'-Fucosyllactose stimulates T cells to increase IFN-γ production and decreases IL-6, IL-17, and TNF-α production of cytokines[1][2].

B-Trisaccharide

(2R,3S,4S)-4,5,6-trihydroxy-3-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexanal

C18H32O15 (488.1741)

B-Trisaccharide in blood group B is formed and excreated due to given Galactose. The B-trisaccharide is the only oligosaccharide detected in plasma after oral galactose administration to a blood-group-B secretor individual. The concentration was 0.38 mg/l of plasma.(PMID: 510288). B-Trisaccharide in blood group B is formed and excreated due to given Galactose.

Fucosyllactose

(2R,3S,4S,5S,6R)-2-{[(2S,3S,4S,5R,6R)-3,5-dihydroxy-2-methoxy-6-({[(2R,3S,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C18H32O15 (488.1741)

Fucosyllactose is an oligosaccharide in human milk that may serve as an anti-inflammatory component and might therefore contribute to the lower incidence of inflammatory diseases in human milk-fed infants. (PMID 15583750) [HMDB] Fucosyllactose is an oligosaccharide in human milk that may serve as an anti-inflammatory component and might therefore contribute to the lower incidence of inflammatory diseases in human milk-fed infants. (PMID 15583750).